Sign in
4

Changes in Ownership

VERTEX PHARMACEUTICALS INC / MA Filed Acc 0000875320-24-000170

EVP & Chief Financial Officer sold 3,250 shares at $460.00 ($1,495,000)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

WAGNER CHARLES F JR · EVP & Chief Financial Officer

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2024-06-03 Sale : show line 1 in the form 10b5-1 −3,250 $460.00 $1,495,000 47,137 D
Open-market sales · 3,250 sh · avg $460.00 · $1,495,000
Loading xslF345X05/wk-form4_1717618308.xml…